Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Related SNY
Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults
Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO
Allergan Reportedly Seeks Alternate Suitor (Fox Business)
Related JNJ
Analysts See No Sweeter Deal For Volcano
Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines
Making Money With Charles Payne: 11/19/14 (Fox Business)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

 

Related Articles (JNJ + SNY)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional